Orakl Oncology

Recent Finacing

Equity

Recent Raise

$3.1M

Orakl Oncology develops a techbio platform that combines biology with patient data to create unique tumor avatars, helping pharma and biotech companies identify new therapeutic targets and increase clinical trial success rates.